RIL
HAE icon

Rothschild Investment LLC’s Haemonetics HAE Stock Holding History

Rothschild Investment LLC’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Buy
211
+10
+5% +$642 ﹤0.01% 1650
2026
Q1 		$11.3K Buy
201
+42
+26% +$2.73K ﹤0.01% 1633
2025
Q4 		$12.7K Buy
159
+157
+7,850% +$10.5K ﹤0.01% 1490
2025
Q3 		$97 Sell
2
-108
-98% -$6.68K ﹤0.01% 3068
2025
Q2 		$8.21K Buy
110
+35
+47% +$2.32K ﹤0.01% 1298
2025
Q1 		$4.77K Buy
75
+15
+25% +$1.02K ﹤0.01% 1460
2024
Q4 		$4.68K Buy
60
+35
+140% +$2.81K ﹤0.01% 1365
2024
Q3 		$2.01K Buy
25
+10
+67% +$808 ﹤0.01% 1724
2024
Q2 		$1.24K Buy
15
+10
+200% +$880 ﹤0.01% 1553
2024
Q1 		$427 Buy
+5
New +$392 ﹤0.01% 1414

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rothschild Investment LLC's HAE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Haemonetics (HAE) stake by 5% in Q2 2026, buying an estimated $642 and bringing the position to 211 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

Rothschild Investment LLC first reported a position in HAE in Q1 2024 and has held it in 10 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Rothschild Investment LLC held 211 shares of Haemonetics worth $15.8K as of Q2 2026.
  • Rothschild Investment LLC bought 10 Haemonetics shares in Q2 2026, an estimated $642.
  • Haemonetics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1650 holding.
  • Rothschild Investment LLC first reported a position in Haemonetics in Q1 2024 and has held it in 10 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.